{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:03:18Z","timestamp":1790434998225,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioMed Eng OnLine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Coronary stents are routinely placed in the treatment and prophylaxis of coronary artery disease (CAD). Current coronary stent designs are prone to developing blockages: in-stent thrombosis (IST) and in-stent re-stenosis (ISR). This is a systematic review of the design of current coronary stent models, their structural properties and their modes of application, with a focus on their associated risks of IST and ISR. The primary aim of this review is to identify the best stent design features for reducing the risk of IST and ISR. To review the three major types of stents used in clinical settings today, determining best and relevant clinical practice by exploring which types and features of offer improved patient outcomes regarding coronary angioplasty. This information can potentially be used to increase the success rate of coronary angioplasty and stent technology in the future taking into account costs and benefits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Scientific databases were searched to find studies concerning stents. After the exclusion criteria were applied, 19 of the 3192 searched literature were included in this review. Studies investigating three major types of stent design were found: bare-metal stents (BMS), drug-eluting stents (DES) and bioresorbable stents (BRS). The number of participants varied between 14 and 1264. On average 77.4% were male, with a mean age of 64\u00a0years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From the findings of these studies, it is clear that DES are superior in reducing the risk of ISR when compared to BMS. Conflicting results do not clarify whether BRS are superior to DES at reducing IST occurrence, although studies into newer BRS technologies show reducing events of IST to 0, creating a promising future for BRS showing them to be non-inferior. Thinner stents were shown to reduce IST rates, due to better re-endothelialisation. Scaffold material has also been shown to play a role with cobalt alloy stents reducing the risk of IST. This study found that thinner stents that release drugs were better at preventing re-blockages. Some dissolvable stents might be better at stopping blood clots blocking the arteries when compared to metal stents. The method and procedure of implanting the stent during coronary angioplasty influences success rate of these stents, meaning stent design is not the only significant factor to consider.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Positive developments in coronary angioplasty could be made by designing new stents that encompass all the most desirable properties of existing stent technology. Further work is needed to investigate the benefits of BRS in reducing the risk of IST compared to DES, as well as to investigate the effects of different scaffold materials on IST and ISR outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12938-021-00883-7","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T08:05:38Z","timestamp":1620461138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Critical evaluation of stents in coronary angioplasty: a systematic review"],"prefix":"10.1186","volume":"20","author":[{"given":"Joseph Robert","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Ian Atkins","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-8022","authenticated-orcid":false,"given":"Mohammad","family":"Akrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"issue":"15","key":"883_CR1","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jacc.2011.12.016","volume":"59","author":"IT Meredith","year":"2012","unstructured":"Meredith IT, Verheye S, Dubois CL, Dens J, Fajadet J, Carri\u00e9 D, et al. Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. J Am Coll Cardiol. 2012;59(15):1362\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"883_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.irbm.2013.11.002","volume":"35","author":"M Harmouche","year":"2014","unstructured":"Harmouche M, Maasrani M, Verhoye J-P, Corbineau H, Drochon A. Coronary three-vessel disease with occlusion of the right coronary artery: what are the most important factors that determine the right territory perfusion? IRBM. 2014;35(3):149\u201357.","journal-title":"IRBM"},{"issue":"4","key":"883_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S0735-1097(98)00333-7","volume":"32","author":"H Eltchaninoff","year":"1998","unstructured":"Eltchaninoff H, Koning R, Tron C, Gupta V, Cribier A. Balloon angioplasty for the treatment of coronary in-stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol. 1998;32(4):980\u20134.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"883_CR4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/jamacardio.2017.2895","volume":"2","author":"D Giacoppo","year":"2017","unstructured":"Giacoppo D, Colleran R, Cassese S, Frangieh AH, Wiebe J, Joner M, et al. Percutaneous coronary intervention vs coronary artery bypass grafting in patients with left main coronary artery stenosis: a systematic review and meta-analysis. JAMA Cardiol. 2017;2(10):1079\u201388.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"883_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/bmb\/ldt009","volume":"106","author":"J Iqbal","year":"2013","unstructured":"Iqbal J, Gunn J, Serruys PW. Coronary stents: historical development, current status and future directions. Br Med Bull. 2013;106(1):193\u2013211.","journal-title":"Br Med Bull"},{"issue":"23","key":"883_CR6","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa012843","volume":"346","author":"M-C Morice","year":"2002","unstructured":"Morice M-C, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346(23):1773\u201380.","journal-title":"N Engl J Med"},{"issue":"10","key":"883_CR7","doi-asserted-by":"publisher","first-page":"E1150","DOI":"10.21037\/jtd.2016.10.93","volume":"8","author":"D Buccheri","year":"2016","unstructured":"Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8(10):E1150.","journal-title":"J Thorac Dis"},{"issue":"22","key":"883_CR8","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1136\/heartjnl-2013-305399","volume":"100","author":"T Pilgrim","year":"2014","unstructured":"Pilgrim T, Windecker S. Antiplatelet therapy for secondary prevention of coronary artery disease. Heart. 2014;100(22):1750\u20136.","journal-title":"Heart"},{"issue":"14","key":"883_CR9","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O\u2019Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315\u201323.","journal-title":"N Engl J Med"},{"issue":"5","key":"883_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0009-9120(98)00045-9","volume":"31","author":"SN Sehgal","year":"1998","unstructured":"Sehgal SN. Rapamune\u00ae (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem. 1998;31(5):335\u201340.","journal-title":"Clin Biochem"},{"issue":"8","key":"883_CR11","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1161\/01.CIR.104.8.852","volume":"104","author":"SO Marx","year":"2001","unstructured":"Marx SO, Marks AR. Bench to bedside. Circulation. 2001;104(8):852\u20135.","journal-title":"Circulation"},{"issue":"6","key":"883_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00392-012-0415-7","volume":"101","author":"B Cremers","year":"2012","unstructured":"Cremers B, Toner JL, Schwartz LB, von Oepen R, Speck U, Kaufels N, et al. Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clin Res Cardiol. 2012;101(6):469\u201376.","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"883_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIRCINTERVENTIONS.109.877522","volume":"3","author":"N Tada","year":"2010","unstructured":"Tada N, Virmani R, Grant G, Bartlett L, Black A, Clavijo C, et al. Polymer-free Biolimus A9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model. Circul Cardiovasc Interven. 2010;3(2):174\u201383.","journal-title":"Circul Cardiovasc Interven"},{"issue":"7","key":"883_CR14","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/01.ATV.0000223866.42883.3b","volume":"26","author":"C Patterson","year":"2006","unstructured":"Patterson C, Mapera S, Li H-H, Madamanchi N, Hilliard E, Lineberger R, et al. Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival. Arterioscler Thromb Vasc Biol. 2006;26(7):1473\u201380.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"883_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA, Hermiller J, O\u2019Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221\u201331.","journal-title":"N Engl J Med"},{"issue":"18","key":"883_CR16","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1161\/01.CIR.103.18.2289","volume":"103","author":"AW Heldman","year":"2001","unstructured":"Heldman AW, Cheng L, Jenkins GM, Heller PF, Kim D-W, Ware M, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation. 2001;103(18):2289\u201395.","journal-title":"Circulation"},{"issue":"9444","key":"883_CR17","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","volume":"364","author":"EP McFadden","year":"2004","unstructured":"McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. The Lancet. 2004;364(9444):1519\u201321.","journal-title":"The Lancet"},{"key":"883_CR18","unstructured":"Forrestal B, Lipinski M. Bioresorbable scaffolds: fading away or hope for the future. J Am Coll Cardiol 2018;7."},{"issue":"23","key":"883_CR19","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","volume":"70","author":"DJ Kereiakes","year":"2017","unstructured":"Kereiakes DJ, Ellis SG, Metzger C, Caputo RP, Rizik DG, Teirstein PS, et al. 3-year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial. J Am Coll Cardiol. 2017;70(23):2852\u201362.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"883_CR20","doi-asserted-by":"publisher","first-page":"e000680","DOI":"10.1136\/openhrt-2017-000680","volume":"4","author":"T Watson","year":"2017","unstructured":"Watson T, Webster MWI, Ormiston JA, Ruygrok PN, Stewart JT. Long and short of optimal stent design. Open Heart. 2017;4(2):e000680.","journal-title":"Open Heart"},{"issue":"9","key":"883_CR21","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.carrev.2020.04.006","volume":"21","author":"M Haude","year":"2020","unstructured":"Haude M, Ince H, Kische S, Toelg R, Van Mieghem NM, Verheye S, et al. Sustained safety and performance of the second-generation sirolimus-eluting absorbable metal scaffold: pooled outcomes of the BIOSOLVE-II and-III trials at 3 years. Cardiovasc Revasc Med. 2020;21(9):1150\u20134.","journal-title":"Cardiovasc Revasc Med"},{"issue":"13S","key":"883_CR22","doi-asserted-by":"publisher","first-page":"B142","DOI":"10.1016\/j.jacc.2018.08.1499","volume":"72","author":"M Lee","year":"2018","unstructured":"Lee M, Wlodarczak A, Bennett J, Torzewski J, Haude M, Vrolix M, et al. TCT-350 safety and performance of the resorbable magnesium scaffold, magmaris in a real world setting-first 400 subjects at 12-month follow-up of the BIOSOLVE-IV registry. J Am Coll Cardiol. 2018;72(13S):B142\u20133.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"883_CR23","doi-asserted-by":"publisher","first-page":"e003610","DOI":"10.1161\/CIRCINTERVENTIONS.115.003610","volume":"9","author":"LO Jensen","year":"2016","unstructured":"Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell LR, Raungaard B, et al. Randomized comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention. Circul Cardiovasc Interven. 2016;9(7):e003610.","journal-title":"Circul Cardiovasc Interven"},{"issue":"12","key":"883_CR24","doi-asserted-by":"publisher","first-page":"e004801","DOI":"10.1161\/CIRCINTERVENTIONS.116.004801","volume":"10","author":"B Chevalier","year":"2017","unstructured":"Chevalier B, Smits PC, Carri\u00e9 D, Mehilli J, Boven AJV, Regar E, et al. Serial Assessment of strut coverage of biodegradable polymer drug-eluting stent at 1, 2, and 3 months after stent implantation by optical frequency domain imaging. Circul Cardiovasc Interven. 2017;10(12):e004801.","journal-title":"Circul Cardiovasc Interven"},{"issue":"10","key":"883_CR25","first-page":"e002518","volume":"8","author":"F Cuculi","year":"2015","unstructured":"Cuculi F, Puricel S, Jamshidi P, Valentin J, Kallinikou Z, Toggweiler S, et al. Optical coherence tomography findings in bioresorbable vascular scaffolds thrombosis. Circul Cardiovasc Interven. 2015;8(10):e002518.","journal-title":"Circul Cardiovasc Interven"},{"key":"883_CR26","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","volume":"115","author":"AV Finn","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC. Pathological correlates of late drug-eluting stent thrombosis. Circulation. 2007;115:2435\u201341.","journal-title":"Circulation"},{"issue":"26","key":"883_CR27","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1093\/eurheartj\/ehv581","volume":"37","author":"T Gori","year":"2015","unstructured":"Gori T, Jansen T, Weissner M, Foin N, Wenzel P, Schulz E, et al. Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms. Eur Heart J. 2015;37(26):2040\u20139.","journal-title":"Eur Heart J"},{"issue":"4","key":"883_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/CIRCINTERVENTIONS.110.950154","volume":"3","author":"G Guagliumi","year":"2010","unstructured":"Guagliumi G, Sirbu V, Musumeci G, Bezerra HG, Aprile A, Kyono H, et al. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer. Circul Cardiovasc Interven. 2010;3(4):367\u201375.","journal-title":"Circul Cardiovasc Interven"},{"issue":"3","key":"883_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1161\/CIRCULATIONAHA.110.963181","volume":"123","author":"G Guagliumi","year":"2011","unstructured":"Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, Suzuki N, et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction. Circulation. 2011;123(3):274\u201381.","journal-title":"Circulation"},{"issue":"1","key":"883_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/CIRCINTERVENTIONS.111.965582","volume":"5","author":"G Guagliumi","year":"2012","unstructured":"Guagliumi G, Bezerra HG, Sirbu V, Ikejima H, Musumeci G, Biondi-Zoccai G, et al. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Circul Cardiovasc Interven. 2012;5(1):30\u20138.","journal-title":"Circul Cardiovasc Interven"},{"issue":"6","key":"883_CR31","doi-asserted-by":"publisher","first-page":"E173","DOI":"10.1002\/ccd.26617","volume":"88","author":"M Jaguszewski","year":"2016","unstructured":"Jaguszewski M, D\u00f6rig M, Frangieh AH, Ghadri J-R, Cammann VL, Diekmann J, et al. Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome. Catheter Cardiovasc Interv. 2016;88(6):E173\u201382.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"883_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.114.013520","volume":"131","author":"C Kaiser","year":"2015","unstructured":"Kaiser C, Galatius S, Jeger R, Gilgen N, Jensen JS, Naber C, et al. Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents. Circulation. 2015;131(1):74\u201381.","journal-title":"Circulation"},{"issue":"14","key":"883_CR33","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/CIRCULATIONAHA.117.028885","volume":"136","author":"DE Kandzari","year":"2017","unstructured":"Kandzari DE, Smits PC, Love MP, Ben-Yehuda O, Banai S, Robinson SD, et al. Randomized comparison of ridaforolimus- and zotarolimus-eluting coronary stents in patients with coronary artery disease. Circulation. 2017;136(14):1304\u201314.","journal-title":"Circulation"},{"issue":"4","key":"883_CR34","doi-asserted-by":"publisher","first-page":"e002372","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372","volume":"8","author":"DJ Kereiakes","year":"2015","unstructured":"Kereiakes DJ, Meredith IT, Windecker S, Jobe RL, Mehta SR, Sarembock IJ, et al. Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. Circul Cardiovasc Interven. 2015;8(4):e002372.","journal-title":"Circul Cardiovasc Interven"},{"issue":"42","key":"883_CR35","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1093\/eurheartj\/eht241","volume":"34","author":"M Nakano","year":"2013","unstructured":"Nakano M, Otsuka F, Yahagi K, Sakakura K, Kutys R, Ladich ER, et al. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur Heart J. 2013;34(42):3304\u201313.","journal-title":"Eur Heart J"},{"issue":"12","key":"883_CR36","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/eurheartj\/ehq066","volume":"31","author":"Y Ozaki","year":"2010","unstructured":"Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S, et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur Heart J. 2010;31(12):1470\u20136.","journal-title":"Eur Heart J"},{"issue":"13","key":"883_CR37","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/eurheartj\/ehi098","volume":"26","author":"J Pache","year":"2005","unstructured":"Pache J, Dibra A, Mehilli J, Dirschinger J, Sch\u00f6mig A, Kastrati A. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. Eur Heart J. 2005;26(13):1262\u20138.","journal-title":"Eur Heart J"},{"issue":"15","key":"883_CR38","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","volume":"58","author":"PW Serruys","year":"2011","unstructured":"Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, et al. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis. J Am Coll Cardiol. 2011;58(15):1578\u201388.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"883_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/joic.12300","volume":"29","author":"S Silenzi","year":"2016","unstructured":"Silenzi S, Grossi P, Mariani L, Fraccaro C, Vagnarelli F, Moretti L. Effect on clinical restenosis of an ultra-thin-strut bare metal cobalt-chromium stent versus a thin-strut stainless steel stent. J Interv Cardiol. 2016;29(3):300\u201310.","journal-title":"J Interv Cardiol"},{"issue":"22","key":"883_CR40","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1093\/eurheartj\/ehm425","volume":"28","author":"R Wessely","year":"2007","unstructured":"Wessely R, Kastrati A, Mehilli J, Dibra A, Pache J, Sch\u00f6mig A. Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design. Eur Heart J. 2007;28(22):2720\u20135.","journal-title":"Eur Heart J"},{"issue":"4","key":"883_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.irbm.2011.05.002","volume":"32","author":"J Velut","year":"2011","unstructured":"Velut J, Lentz P-A, Boulmier D, Coatrieux J-L, Toumoulin C. Assessment of qualitative and quantitative features in coronary artery MRA. IRBM. 2011;32(4):229\u201342.","journal-title":"IRBM"},{"issue":"4\u20135","key":"883_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.irbm.2013.08.004","volume":"34","author":"H Feuill\u00e2tre","year":"2013","unstructured":"Feuill\u00e2tre H, Sanokho B, Nunes J-C, Bedossa M, Toumoulin C. Automatic determination of optimal view for the visualization of coronary lesions by rotational X-ray angiography. IRBM. 2013;34(4\u20135):291\u20135.","journal-title":"IRBM"},{"issue":"1","key":"883_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12938-016-0307-6","volume":"16","author":"H Li","year":"2017","unstructured":"Li H, Liu T, Wang M, Zhao D, Qiao A, Wang X, et al. Design optimization of stent and its dilatation balloon using kriging surrogate model. Biomed Eng Online. 2017;16(1):13.","journal-title":"Biomed Eng Online"},{"issue":"2","key":"883_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12938-016-0268-9","volume":"15","author":"H Li","year":"2016","unstructured":"Li H, Gu J, Wang M, Zhao D, Li Z, Qiao A, et al. Multi-objective optimization of coronary stent using Kriging surrogate model. Biomed Eng Online. 2016;15(2):148.","journal-title":"Biomed Eng Online"},{"key":"883_CR45","unstructured":"Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0: The Cochrane Collaboration. 2011."},{"key":"883_CR46","first-page":"12","volume":"9","author":"S Geraci","year":"2010","unstructured":"Geraci S, La Manna A, Tamburino C. Optical coherence tomography for coronary imaging. J Cardiol Pract. 2010;9:12.","journal-title":"J Cardiol Pract"},{"issue":"17","key":"883_CR47","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Es G-A, et al. Clinical end points in coronary stent trials. Circulation. 2007;115(17):2344\u201351.","journal-title":"Circulation"},{"issue":"3","key":"883_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.irbm.2017.04.004","volume":"38","author":"S Mabrouk","year":"2017","unstructured":"Mabrouk S, Oueslati C, Ghorbel F. Multiscale graph cuts based method for coronary artery segmentation in angiograms. IRBM. 2017;38(3):167\u201375.","journal-title":"IRBM"},{"issue":"6","key":"883_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.irbm.2020.06.011","volume":"41","author":"AF Kouvahe","year":"2020","unstructured":"Kouvahe AF, Fetita C. A generic approach for efficient detection of vascular structures. IRBM. 2020;41(6):304\u201315.","journal-title":"IRBM"},{"issue":"12","key":"883_CR50","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jacc.2013.01.007","volume":"61","author":"ML Fokkema","year":"2013","unstructured":"Fokkema ML, James SK, Albertsson P, Akerblom A, Calais F, Eriksson P, et al. Population trends in percutaneous coronary intervention. J Am Coll Cardiol. 2013;61(12):1222\u201330.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"883_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-14-632","volume":"14","author":"G Zacca-Gonz\u00e1lez","year":"2014","unstructured":"Zacca-Gonz\u00e1lez G, Chinchilla-Rodr\u00edguez Z, Vargas-Quesada B, de Moya-Aneg\u00f3n F. Bibliometric analysis of regional Latin America\u2019s scientific output in public health through SCImago journal & country rank. BMC Public Health. 2014;14(1):1\u201311.","journal-title":"BMC Public Health"},{"issue":"1","key":"883_CR52","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","volume":"31","author":"R Kornowski","year":"1998","unstructured":"Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31(1):224\u201330.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"883_CR53","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1161\/01.CIR.0000019071.72887.BD","volume":"105","author":"A Farb","year":"2002","unstructured":"Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 2002;105(25):2974\u201380.","journal-title":"Circulation"},{"issue":"1","key":"883_CR54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/01.CIR.99.1.44","volume":"99","author":"A Farb","year":"1999","unstructured":"Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99(1):44\u201352.","journal-title":"Circulation"},{"issue":"23","key":"883_CR55","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","volume":"103","author":"A Kastrati","year":"2001","unstructured":"Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Sch\u00fchlen H, Neumann F-J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation. 2001;103(23):2816\u201321.","journal-title":"Circulation"},{"issue":"8","key":"883_CR56","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0735-1097(03)00119-0","volume":"41","author":"J Pache","year":"2003","unstructured":"Pache J, Kastrati A, Mehilli J, Sch\u00fchlen H, Dotzer F, Hausleiter J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol. 2003;41(8):1283\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"883_CR57","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.amjcard.2003.10.049","volume":"93","author":"SZ Rittersma","year":"2004","unstructured":"Rittersma SZ, de Winter RJ, Koch KT, Bax M, Schotborgh CE, Mulder KJ, et al. Impact of strut thickness on late luminal loss after coronary artery stent placement. Am J Cardiol. 2004;93(4):477\u201380.","journal-title":"Am J Cardiol"},{"issue":"2","key":"883_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/eurheartj\/ehp480","volume":"31","author":"P Barlis","year":"2010","unstructured":"Barlis P, Regar E, Serruys PW, Dimopoulos K, van der Giessen WJ, van Geuns R-JM, et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J. 2010;31(2):165\u201376.","journal-title":"Eur Heart J"},{"issue":"25","key":"883_CR59","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/j.jacc.2012.02.027","volume":"59","author":"A Belkacemi","year":"2012","unstructured":"Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Belle EV, et al. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial. J Am Coll Cardiol. 2012;59(25):2327\u201337.","journal-title":"J Am Coll Cardiol"},{"issue":"42","key":"883_CR60","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1093\/eurheartj\/ehx351","volume":"38","author":"T Kubo","year":"2017","unstructured":"Kubo T, Shinke T, Okamura T, Hibi K, Nakazawa G, Morino Y, et al. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results. Eur Heart J. 2017;38(42):3139\u201347.","journal-title":"Eur Heart J"},{"issue":"7","key":"883_CR61","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","volume":"27","author":"AV Finn","year":"2007","unstructured":"Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27(7):1500\u201310.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"883_CR62","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/CIRCINTERVENTIONS.113.000120","volume":"6","author":"MJ Eppihimer","year":"2013","unstructured":"Eppihimer MJ, Sushkova N, Grimsby JL, Efimova N, Kai W, Larson S, et al. Impact of stent surface on thrombogenicity and vascular healing. Circul Cardiovasc Interven. 2013;6(4):370\u20137.","journal-title":"Circul Cardiovasc Interven"},{"issue":"18","key":"883_CR63","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.106.658237","volume":"115","author":"S Cook","year":"2007","unstructured":"Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426\u201334.","journal-title":"Circulation"},{"key":"883_CR64","doi-asserted-by":"publisher","first-page":"F28","DOI":"10.4244\/EIJV5IFA5","volume":"5","author":"M Vorpahl","year":"2009","unstructured":"Vorpahl M, Finn AV, Nakano M, Virmani R. The bioabsorption process: tissue and cellular mechanisms and outcomes. EuroIntervention. 2009;5:F28\u201335.","journal-title":"EuroIntervention"},{"issue":"22","key":"883_CR65","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1161\/CIRCULATIONAHA.109.921528","volume":"122","author":"Y Onuma","year":"2010","unstructured":"Onuma Y, Serruys PW, Perkins LEL, Okamura T, Gonzalo N, Garc\u00eda-Garc\u00eda HM, et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model. Circulation. 2010;122(22):2288\u2013300.","journal-title":"Circulation"},{"issue":"1","key":"883_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans. J Am Coll Cardiol. 2006;48(1):193\u2013202.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"883_CR67","first-page":"567","volume":"57","author":"RA Byrne","year":"2009","unstructured":"Byrne RA, Joner M, Kastrati A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol. 2009;57(5):567\u201384.","journal-title":"Minerva Cardioangiol"},{"key":"883_CR68","unstructured":"Ellis SG, Kereiakes DJ, Stone GW, editors. Everolimus-eluting bioresorbable vascular scaffolds in patients with coronary artery disease: ABSORB III trial 2-year results. In: Annual Meeting of the American College of Cardiology; 2017."},{"issue":"3","key":"883_CR69","first-page":"115","volume":"23","author":"P Sojitra","year":"2010","unstructured":"Sojitra P, Engineer C, Kothwala D, Raval A, Kotadia H, Mehta G. Electropolishing of 316LVM stainless steel cardiovascular stents: an investigation of material removal, surface roughness and corrosion behaviour. Artif Organs. 2010;23(3):115\u201321.","journal-title":"Artif Organs"},{"issue":"6","key":"883_CR70","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/heart.89.6.651","volume":"89","author":"B Heublein","year":"2003","unstructured":"Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart. 2003;89(6):651\u20136.","journal-title":"Heart"},{"issue":"10157","key":"883_CR71","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/S0140-6736(18)32283-9","volume":"392","author":"GW Stone","year":"2018","unstructured":"Stone GW, Ellis SG, Gori T, Metzger DC, Stein B, Erickson M, et al. Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial. The Lancet. 2018;392(10157):1530\u201340.","journal-title":"The Lancet"}],"container-title":["BioMedical Engineering OnLine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-021-00883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12938-021-00883-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-021-00883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T23:04:05Z","timestamp":1675292645000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomedical-engineering-online.biomedcentral.com\/articles\/10.1186\/s12938-021-00883-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["883"],"URL":"https:\/\/doi.org\/10.1186\/s12938-021-00883-7","relation":{},"ISSN":["1475-925X"],"issn-type":[{"value":"1475-925X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"assertion":[{"value":"27 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}